{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:53:32Z","timestamp":1779224012664,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007065","name":"Nvidia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["316213987"],"award-info":[{"award-number":["316213987"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1278"],"award-info":[{"award-number":["SFB 1278"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["239748522"],"award-info":[{"award-number":["239748522"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1127"],"award-info":[{"award-number":["SFB1127"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00dcB\u0130TAK","doi-asserted-by":"publisher","award":["218S555"],"award-info":[{"award-number":["218S555"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bioorg.2024.107383","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T12:56:41Z","timestamp":1713272201000},"page":"107383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Novel 1,3,4-oxadiazole derivatives as highly potent microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors"],"prefix":"10.1016","volume":"147","author":[{"given":"Tu\u011f\u00e7e","family":"G\u00fcr Maz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Dahlke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azize","family":"Gizem Erg\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdurrahman","family":"Ol\u011fa\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcu","family":"\u00c7al\u0131\u015fkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Werz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erden","family":"Banoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.bioorg.2024.107383_b0005","first-page":"3","article-title":"Arachidonic acid metabolism: role in inflammation","volume":"50","author":"Samuelsson","year":"1991","journal-title":"Z. Rheumatol."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107383_b0010","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/med.21424","article-title":"Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety","volume":"37","author":"Pereira-Leite","year":"2017","journal-title":"Med. Res. Rev."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107383_b0015","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/14740338.2017.1338272","article-title":"Nonsteroidal anti-inflammatory drugs and cardiovascular safety - translating pharmacological data into clinical readouts","volume":"16","author":"Tacconelli","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107383_b0020","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1039\/C2MB05503A","article-title":"Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network","volume":"8","author":"He","year":"2012","journal-title":"Mol. Biosyst."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107383_b0025","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1096\/fj.201802509R","article-title":"Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome","volume":"33","author":"Werner","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bioorg.2024.107383_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104861","article-title":"Simple heteroaryl modifications in the 4,5-diarylisoxazol-3-carboxylic acid scaffold favorably modulates the activity as dual mPGES-1\/5-LO inhibitors with in vivo efficacy","volume":"112","author":"Gurses","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107383_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2015.06.022","article-title":"Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders","volume":"98","author":"Koeberle","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"42","key":"10.1016\/j.bioorg.2024.107383_b0040","doi-asserted-by":"crossref","first-page":"32783","DOI":"10.1074\/jbc.M003505200","article-title":"Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2","volume":"275","author":"Murakami","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107383_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2019.106383","article-title":"A review on mPGES-1 inhibitors: From preclinical studies to clinical applications","volume":"147","author":"Bergqvist","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"9","key":"10.1016\/j.bioorg.2024.107383_b0050","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/0008-5472.CAN-07-6100","article-title":"Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis","volume":"68","author":"Nakanishi","year":"2008","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107383_b0055","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.21873\/anticanres.14888","article-title":"Gene Deletion of Microsomal Prostaglandin E Synthase-1 Suppresses Chemically Induced Skin Carcinogenesis","volume":"41","author":"Sasaki","year":"2021","journal-title":"Anticancer Res"},{"issue":"38","key":"10.1016\/j.bioorg.2024.107383_b0060","doi-asserted-by":"crossref","first-page":"29254","DOI":"10.1074\/jbc.M110.114454","article-title":"Identification of key residues determining species differences in inhibitor binding of microsomal prostaglandin E synthase-1","volume":"285","author":"Pawelzik","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107383_b0065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bcp.13423","article-title":"Dose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor","volume":"84","author":"Jin","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107383_b0070","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/cpt.260","article-title":"Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin e synthase 1 inhibitor, with celecoxib","volume":"99","author":"Jin","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107383_b0075","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1016\/j.ejmech.2011.08.009","article-title":"Pyrazol-3-propanoic acid derivatives as novel inhibitors of leukotriene biosynthesis in human neutrophils","volume":"46","author":"Caliskan","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107383_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114167","article-title":"Novel potent benzimidazole-based microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C(4) synthase","volume":"231","author":"Ergul","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107383_b0085","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ejmech.2018.03.045","article-title":"Identification of multi-target inhibitors of leukotriene and prostaglandin E2 biosynthesis by structural tuning of the FLAP inhibitor BRP-7","volume":"150","author":"Gur","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107383_b0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jpba.2013.10.039","article-title":"Chromatographic separation and biological evaluation of benzimidazole derivative enantiomers as inhibitors of leukotriene biosynthesis","volume":"89","author":"Sardella","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107383_b0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/cmdc.201800701","article-title":"A Multi-step Virtual Screening Protocol for the Identification of Novel Non-acidic Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors","volume":"14","author":"Shekfeh","year":"2019","journal-title":"ChemMedChem"},{"issue":"56","key":"10.1016\/j.bioorg.2024.107383_b0100","doi-asserted-by":"crossref","first-page":"45535","DOI":"10.1039\/C5RA01428J","article-title":"2,5-Diaryl-1,3,4-oxadiazoles as selective COX-2 inhibitors and anti-inflammatory agents","volume":"5","author":"Grover","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2024.107383_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105068","article-title":"Investigation of indole functionalized pyrazoles and oxadiazoles as anti-inflammatory agents: Synthesis, in-vivo, in-vitro and in-silico analysis","volume":"114","author":"Kumar","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107383_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113693","article-title":"Structure-based screening for the discovery of 1,2,4-oxadiazoles as promising hits for the development of new anti-inflammatory agents interfering with eicosanoid biosynthesis pathways","volume":"224","author":"Potenza","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107383_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129800","article-title":"Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP)","volume":"1865","author":"Ho","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"13","key":"10.1016\/j.bioorg.2024.107383_b0120","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1021\/acs.jmedchem.5b01750","article-title":"Design and Development of Microsomal Prostaglandin E2 Synthase-1 Inhibitors: Challenges and Future Directions","volume":"59","author":"Koeberle","year":"2016","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107383_b0125","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1021\/acs.jmedchem.5b00330","article-title":"Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics","volume":"58","author":"Luz","year":"2015","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107383_b0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/acs.jmedchem.5b01249","article-title":"Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors","volume":"59","author":"Schiffler","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107383_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2016.02.027","article-title":"4,5-Diarylisoxazol-3-carboxylic acids: A new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein","volume":"113","author":"Banoglu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107383_b0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bcp.2016.08.023","article-title":"BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase\/5-lipoxygenase-activating protein (FLAP) complex assembly","volume":"119","author":"Garscha","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107383_b0145","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1021\/jm2013248","article-title":"Oxadiazoles in medicinal chemistry","volume":"55","author":"Bostrom","year":"2012","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107383_b0150","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2174\/13895575113139990071","article-title":"1,3,4-oxadiazole derivatives as potential biological agents","volume":"13","author":"Sun","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107383_b0155","doi-asserted-by":"crossref","first-page":"436","DOI":"10.35333\/jrp.2020.187","article-title":"Synthesis, in silico studies and cytotoxicity evaluation of novel 1,3,4-oxadiazole derivatives designed as potential mPGES-1 inhibitors","volume":"24","author":"Erensoy","year":"2020","journal-title":"J Res Pharm"},{"key":"10.1016\/j.bioorg.2024.107383_b0160","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ejmech.2018.05.041","article-title":"Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO\/m-PGES-1 dual inhibitors able to suppress inflammation","volume":"155","author":"Bruno","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107383_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108247","article-title":"Staphylococcus aureus-Derived alpha-Hemolysin Evokes Generation of Specialized Pro-resolving Mediators Promoting Inflammation Resolution","volume":"33","author":"Jordan","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107383_b0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41467-017-02538-5","article-title":"Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity","volume":"9","author":"Werz","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107383_b0175","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1189\/jlb.0906576","article-title":"Regulation of the microsomal prostaglandin E synthase-1 in polarized mononuclear phagocytes and its constitutive expression in neutrophils","volume":"82","author":"Mosca","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bioorg.2024.107383_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106738","article-title":"Microsomal prostaglandin E synthase-1 inhibition promotes shunting in arachidonic acid metabolism during inflammatory responses in vitro","volume":"167","author":"Liu","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"39","key":"10.1016\/j.bioorg.2024.107383_b0185","doi-asserted-by":"crossref","first-page":"14507","DOI":"10.1073\/pnas.0606586103","article-title":"Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis","volume":"103","author":"Wang","year":"2006","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107383_b0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/bcpt.12162","article-title":"Characterization of microsomal prostaglandin E synthase 1 inhibitors","volume":"114","author":"Korotkova","year":"2014","journal-title":"Basic Clin. Paharmacol. Toxicol."},{"key":"10.1016\/j.bioorg.2024.107383_b0195","unstructured":"Schr\u00f6dinger Release 2023-2: Prime, Schr\u00f6dinger, LLC, New York, NY, 2023."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107383_b0200","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/bioinformatics\/btk023","article-title":"OPM: Orientations of Proteins in Membranes Database","volume":"22","author":"Lomize","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bioorg.2024.107383_b0205","unstructured":"Schr\u00f6dinger Release 2023-2: Maestro, Schr\u00f6dinger, LLC, New York, NY, 2023."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107383_b0210","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1021\/cg500157x","article-title":"Crystallizing Membrane Proteins in the Lipidic Mesophase. Experience with Human Prostaglandin E2 Synthase 1 and an Evolving Strategy","volume":"14","author":"Li","year":"2014","journal-title":"Cryst. Growth Des."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107383_b0215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nmeth.3211","article-title":"Fast native-SAD phasing for routine macromolecular structure determination","volume":"12","author":"Weinert","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bioorg.2024.107383_b0220","unstructured":"The PyMOL Molecular Graphics System, Version 2.5 Schr\u00f6dinger, LLC."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107383_b0225","first-page":"422","article-title":"Cyclooxygenase inhibitors: From pharmacology to clinical read-outs","volume":"1851","author":"Patrignani","year":"2015","journal-title":"BBA"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107383_b0230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12951-020-00620-7","article-title":"Encapsulation of the dual FLAP\/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity","volume":"18","author":"Shkodra-Pula","year":"2020","journal-title":"J Nanobiotechnology"},{"issue":"15","key":"10.1016\/j.bioorg.2024.107383_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/polym13152557","article-title":"Effect of Crystallinity on the Properties of Polycaprolactone Nanoparticles Containing the Dual FLAP\/mPEGS-1 Inhibitor BRP-187","volume":"13","author":"Vollrath","year":"2021","journal-title":"Polymers (basel)"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107383_b0240","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0968-0896(02)00611-9","article-title":"Synthesis and in vitro leishmanicidal activity of some hydrazides and their analogues","volume":"11","author":"Khan","year":"2003","journal-title":"Bioorg. Med. Chem."},{"issue":"09","key":"10.1016\/j.bioorg.2024.107383_b0245","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1055\/s-0034-1380493","article-title":"Photocatalytic Oxidative Heterocyclization of Semicarbazones: An Efficient Approach for the Synthesis of 1,3,4-Oxadiazoles","volume":"26","author":"Kapoorr","year":"2015","journal-title":"Synlett"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107383_b0250","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1124\/jpet.108.139444","article-title":"Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1","volume":"326","author":"Koeberle","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2024.107383_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114825","article-title":"Natural chalcones elicit formation of specialized pro-resolving mediators and related 15-lipoxygenase products in human macrophages","volume":"195","author":"Kretzer","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"13","key":"10.1016\/j.bioorg.2024.107383_b0260","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1021\/jm500308c","article-title":"SAR studies on curcumin's pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase","volume":"57","author":"Koeberle","year":"2014","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107383_b0265","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1172\/JCI92885","article-title":"Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males","volume":"127","author":"Pace","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107383_b0270","doi-asserted-by":"crossref","first-page":"C39","DOI":"10.1152\/ajpcell.00024.2014","article-title":"Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue","volume":"307","author":"Colas","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107383_b0275","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.bmcl.2016.11.011","article-title":"Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1","volume":"27","author":"Partridge","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107383_b0280","series-title":"2023\u20132: Schr\u00f6dinger Suite 2023\u20132 Protein Preparation Wizard; Epik, Schr\u00f6dinger, LLC, New York, NY, Impact, Schr\u00f6dinger, LLC, New York, NY, 2023","first-page":"2023","author":"Release","year":"2023"},{"key":"10.1016\/j.bioorg.2024.107383_b0285","unstructured":"Schr\u00f6dinger Release 2023-2: LigPrep, Schr\u00f6dinger, LLC, New York, NY, 2023."},{"key":"10.1016\/j.bioorg.2024.107383_b0290","unstructured":"Schr\u00f6dinger Release 2022-3: Glide, Schr\u00f6dinger, LLC, New York, NY, 2022."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107383_b0295","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107383_b0300","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107383_b0305","series-title":"Maestro-Desmond Interoperability Tools","first-page":"2023","author":"Schr\u00f6dinger Release 2023\u20132: Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY","year":"2023"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824002888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824002888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:57:11Z","timestamp":1777463831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824002888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":61,"alternative-id":["S0045206824002888"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107383","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel 1,3,4-oxadiazole derivatives as highly potent microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107383"}}